Is a complete NVNO research report available?

No complete published report is available for enVVeno Medical Corporation (NVNO) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

enVVeno Medical Corporation (NVNO)

NASDAQ: NVNO · USD

$10.6

+0.23 (+2.2%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first NVNO analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	7.1M
Net income (ttm)	-18.8M
EPS (ttm)	-$31.0
Shares out	667.7K
Volume	2,356.182
Beta	1.09

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -18.8M
EPS (ttm): -$31.0
Market cap: 7.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All NVNO indicators

Market & fundamental data

Available fields

172

Groups with data

Currency

USD

Showing 172 of 172 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001661053
Company name	enVVeno Medical Corporation
Country	United States
Country code	US
Cusip	29415J205
Employees	33
Employees Change	-4%
Employees Change Percent	-10.81
Enterprise value	$-17.4M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
Industry PE	41
Industry PE Fwd	19.92
Isin	US29415J2050
Last refreshed	2026-07-31
Market cap	$7.1M
Market cap category	Nano-Cap
Price	$10.63
Price currency	USD
Sector	Healthcare
Sector PE	45.56
Sector PE Fwd	24.38
Sic	3841
Symbol	NVNO
Website	https://www.envveno.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-273.11%
FCF yield	-214.69%
P/B ratio	0.29x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-18.8M
Net Income Growth Quarters	3%
Net Income Growth Years	3%
Profit Per Employee	$-570,242
ROA	-37.51
Roa5y	-32.83
ROCE	-83.52
ROE	-60.65
Roe5y	-53.54
ROIC	-39.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-93.8%
Cagr3y	-60.92%
Cagr5y	-45.38%
EPS Growth Quarters	3
EPS Growth Years	3
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$26.1M
Cash	$24.9M
Current Assets	$25.5M
Current Liabilities	$2.1M
Debt	$603,000
Debt Equity	$0.03
Equity	$23.7M
Liabilities	$2.4M
Long Term Assets	$608,000
Long Term Liabilities	$207,000
Net Cash	$24.3M
Net Cash By Market Cap	$353
Net Cash Growth	-35.92%
Net Debt Equity	$-1.02
Tangible Book Value	$23.7M
Tangible Book Value Per Share	$36.2
WACC	9.42

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	11.89
Net Working Capital	$-1.2M
Quick ratio	11.63
Working Capital	$23.3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-16.65%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-93.79%
200-day SMA	12.92
3Y total return	-94.04%
50-day SMA	10.65
50-day SMA vs 200-day SMA	50under200
5Y total return	-95.13%
All Time High	4,935
All Time High Change	-99.78%
All Time High Date	2018-05-31
All Time Low	8.67
All Time Low Change	22.56%
All Time Low Date	2026-02-17
ATR	0.66
Beta	1.09
Beta1y	2.36
Beta2y	1.71
Ch YTD	-5.36
High	10.7
High52	179.6
High52 Date	2025-08-06
High52ch	-94.08%
Low	10.3
Low52	8.67
Low52 Date	2026-02-17
Low52ch	22.56%
Ma50ch	-0.2%
Price vs 200-day SMA	-17.75%
RSI	50.21
RSI Monthly	32.77
RSI Weekly	36.91
Sharpe ratio	-1.56x
Sortino ratio	-1.76
Total Return	-16.65%
Tr YTD	-5.36
Tr1m	-3.84%
Tr1w	5.11%
Tr3m	-0.78%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-20M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	486,208%
Float Percent	72.82%
Shares Insiders	8.89%
Shares Institutions	7.03%
Shares Out	667,669
Shares Qo Q	5.96%
Shares Yo Y	16.65%
Short Float	2.23%
Short Ratio	0.67
Short Shares	1.62

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-18M
Adjusted OCF	-18,024,000
Average Volume	23,208.7x
Bv Per Share	36.2
CAPEX	$-5,000
Ch1m	-3.84
Ch1w	5.11
Ch1y	-93.79
Ch3m	-0.78
Ch3y	-94.04
Ch5y	-95.13
Ch6m	6.16
Change	2.18%
Change From Open	-0.69
Close	10.4
Days Gap	2.88
Depreciation Amortization	127,000
Dollar Volume	25,037.3
Earnings Date	2026-08-06
Earnings Time	bmo
EBIT	$-20M
EBITDA	$-19.9M
EPS	$-30.99
F Score	1
FCF	$-14.8M
FCF EV Yield	84.84x
FCF Per Share	$-22.16
Financing CF	1,023,000
Fiscal Year End	December
Founded	1,987
Investing CF	13,425,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Date	2026-01-20
Last Split Type	Reverse
Last10k Filing Date	2026-03-26
Ma150	10.89
Ma150ch	-2.42%
Ma20	10.72
Ma20ch	-0.85%
Net CF	-340,000
Next Earnings Date	2026-08-11
Open	10.7
Optionable	Yes
Position In Range	81.55
Ppne	577,000
Price Date	2026-07-30
Ptbv Ratio	0.29
Relative Volume	0.1x
Share Based Comp	3,236,000
Tr6m	6.16%
Us State	California
Volume	2,356.2

enVVeno Medical Corporation (NVNO)

Coverage state: Market snapshot only — no published research

Generate the first NVNO analysis

Price

Financial snapshot

Fair-value bridge

Latest news · NVNO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NVNO indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on NVNO

Frequently asked questions